SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-18-021384
Filing Date
2018-05-02
Accepted
2018-05-02 20:52:38
Documents
2
Period of Report
2018-05-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 7267
2 POWER OF ATTORNEY. goeltz_poa.htm EX-24 8898
  Complete submission text file 0001140361-18-021384.txt   17682
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Issuer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 343 OYSTER POINT BLVD SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address
Goeltz II Robert C. (Reporting) CIK: 0001653881 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38470 | Film No.: 18801496